Amanote Research

Amanote Research

    RegisterSign In

Intravenous Digoxin as a Bioavailability Standard

Clinical Pharmacology and Therapeutics - United States
doi 10.1002/cpt1975171117
Full Text
Open PDF
Abstract

Available in full text

Categories
Pharmacology
Date

January 1, 1975

Authors
Roger G. StollJohn G. WagnerDavid J. GreenblattDavid W. DuhmeJan Koch-WeserThomas W. SmithW. J. TilstoneP. C. Reavey
Publisher

Wiley


Related search

The Bioavailability of Digoxin

The Lancet
Medicine
1972English

Bioavailability of Digoxin From Rapidly Dissolving Preparations

British Journal of Clinical Pharmacology
Pharmacology
1974English

Massive Digoxin Overdose: Successful Treatment With Intravenous Amiodarone.

BMJ
1983English

Digoxin Toxicity Presenting as Encephalopathy.

Postgraduate Medical Journal
Medicine
1996English

Bioavailability of Intravenous Fosphenytoin Sodium in Healthy Japanese Volunteers

European Journal of Drug Metabolism and Pharmacokinetics
Pharmacology
2012English

Mathematical Models of the Pharmacokinetic Behavior of Digoxin in Five Healthy Subjects Following Rapid Intravenous Injection of 1 Mg of Digoxin

Journal of Developing Drugs
2015English

Relationship of Plasma Digitoxin and Digoxin to Cardiac Response Following Intravenous Digitalization in Man

Circulation
Cardiovascular MedicinePhysiologyCardiology
1970English

Bioavailability of the Antiemetic Metopimazine Given as a Microenema

British Journal of Clinical Pharmacology
Pharmacology
2003English

IDPR as a Proposed Standard

1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy